IntroductionThe development of cancer immunotherapy has accelerated in recent years. Understanding the specificity of T cell receptors (TCR) for peptides presented by the major histocompatibility comp
IntroductionThe development of cancer immunotherapy has accelerated in recent years. Understanding the specificity of T cell receptors (TCR) for peptides presented by the major histocompatibility comp
IntroductionThe development of cancer immunotherapy has accelerated in recent years. Understanding the specificity of T cell receptors (TCR) for peptides presented by the major histocompatibility comp
Type 1 diabetes (T1D) is the result of the autoimmune attack of autoantigen specific CD8+ and CD4+ T-cells against the pancreatic beta cells, resulting in a deficit of insulin secretion with unwanted
IntroductionThe development of cancer immunotherapy has accelerated in recent years. Understanding the specificity of T cell receptors (TCR) for peptides presented by the major histocompatibility comp